Dexcom Inc. Aktie
75,78 €
Deine Einschätzung
Dexcom Inc. Aktie
Was spricht für und gegen Dexcom Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Dexcom Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Dexcom Inc. | 2,13 % | 1,72 % | -2,19 % | -28,58 % | -2,28 % | -10,06 % | -18,49 % |
Henry Schein Inc. | -1,13 % | 3,04 % | -1,34 % | -4,75 % | -7,43 % | -18,14 % | 7,24 % |
Teleflex Inc. | 0,00 % | 3,14 % | -3,43 % | -52,18 % | -41,37 % | -62,12 % | -69,97 % |
Baxter International | 2,08 % | 1,83 % | -7,11 % | -25,23 % | -12,04 % | -61,70 % | -68,08 % |
Kommentare
News

Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years
Medical device specialist DexCom (NASDAQ: DXCM) has encountered significant headwinds in the past year. The company's financial results haven't been quite up to the market's standards, and broader

Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company’s one-of-a-kind NIL (Name, Image and Likeness) program

2 Stocks to Buy on the Dip and Hold for 10 Years
One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but